Hologic, Inc. (NASDAQ:HOLX) will speak at the JP Morgan Healthcare Conference on January 12, 2010. Representing the company will be Hologic President and Chief Executive Officer Rob Cascella, and Chief Financial Officer Glenn Muir. The company is scheduled to present at 3:30 pm PT that afternoon. Interested parties may listen to a live webcast of the presentation on the company’s investor website, www.hologic.com/investor. The webcast will be archived on the site for instant replay following the conclusion of the event.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
Hologic, Inc. (Hologic) is a developer, manufacturer and supplier of medical imaging systems and diagnostic and surgical products focused on the healthcare needs of women. It operates in four segments: Breast Health, Diagnostics, GYN Surgical and Skeletal Health. The Company had developed a breast imaging platform, Dimensions, which utilizes a technology, tomosynthesis, to produce three dimensional (3D) images, as well as conventional two dimensional (2D) full field digital mammography (FFDM) images. On August 27, 2009, it received the United States Food & Drug Administration (FDA) clearance for its MammoSite ML radiation therapy system, a multi-lumen device. In July 2009, it received FDA approval of the Adiana System.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
